{"schema_version":"1","generated_at":"2026-11-15T03:12:00.582Z","data_as_of":"2026-11-09","url":"https://www.findmykol.com/kol/bartomeu-massuti","json_url":"https://www.findmykol.com/kol/bartomeu-massuti/profile.json","record_kind":"full","profile_kind":"research","person":{"slug":"bartomeu-massuti","name":"Bartomeu Massutí","title":"Jefe del Servicio de Oncología Médica (Head of Medical Oncology), Hospital Doctor Balmis de Alicante","specialty":"Medicine","therapeutic_area":"Lung","therapeutic_areas":["Lung","Gastrointestinal","Oncology"],"institution":"Hospital General Universitario Doctor Balmis de Alicante","institution_url":"https://www.findmykol.com/institution/hospital-general-universitario-doctor-balmis-de-alicante","register":{"country":"ES"}},"identifiers":{"orcid":"0000-0002-6247-4493","openalex":"A5013884017"},"summary":"Bartomeu Massutí is Jefe del Servicio de Oncología Médica (Head of Medical Oncology), Hospital Doctor Balmis de Alicante at Hospital General Universitario Doctor Balmis de Alicante. OpenAlex indexes 390 publications with 20,658 citations (h-index 56); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.","overview":{"text":"Bartomeu Massutí is Jefe del Servicio de Oncología Médica (Head of Medical Oncology), Hospital Doctor Balmis de Alicante at Hospital General Universitario Doctor Balmis de Alicante. The public record shows 390 publications with 20,658 citations (h-index 56), centered on Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies. It also documents an investigator role on 3 registered clinical trials.","bullets":["Most recent indexed publication: 2025 · Oncoimmunology","Top research focus: Lung Cancer Treatments and Mutations","3 registered trials on ClinicalTrials.gov"],"generated_at":"2026-11-14"},"focus":{"indications":[{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":7},{"label":"Small Cell Lung Carcinoma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Carcinoma, Small Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Lung Diseases","therapeutic_area":"Respiratory","trials":1,"topics":0,"strength":3},{"label":"Acromegaly","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Colorectal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"COVID-19","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Gastroesophageal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Head & Neck Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Hepatobiliary Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"HIV","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Idiopathic Pulmonary Fibrosis","therapeutic_area":"Respiratory","trials":0,"topics":0,"strength":1},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Lymphoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Melanoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Osteoporosis","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Ovarian / Gynecologic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Pancreatic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Rheumatoid Arthritis","therapeutic_area":"Rheumatology/Immunology","trials":0,"topics":0,"strength":1}],"research_topics":["Lung Cancer Treatments and Mutations","Lung Cancer Diagnosis and Treatment","Lung Cancer Research Studies","Colorectal Cancer Treatments and Studies","HER2/EGFR in Cancer Research"],"works_with":{"total":1,"shown":1,"withheld":0,"rows":[{"name":"Fundación GECP","trials":3,"payments":0,"mentions":3}]}},"scholarship":{"works_count":390,"cited_by_count":20658,"h_index":56,"i10_index":144,"pubmed_count":3,"latest_activity_year":2025,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07153445","title":"Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC)","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"Fundación GECP","source_url":"https://clinicaltrials.gov/study/NCT07153445","trial_url":"https://www.findmykol.com/trial/NCT07153445"},{"nct":"NCT06431633","title":"Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.","phase":"PHASE3","status":"RECRUITING","role":"Investigator","sponsor":"Fundación GECP","source_url":"https://clinicaltrials.gov/study/NCT06431633","trial_url":"https://www.findmykol.com/trial/NCT06431633"},{"nct":"NCT05398094","title":"Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"Fundación GECP","source_url":"https://clinicaltrials.gov/study/NCT05398094","trial_url":"https://www.findmykol.com/trial/NCT05398094"}],"source":"trials"},"payments":{"note":"Not attributed. This person has no U.S. clinical registration (NPI) on file, so industry payments cannot be reliably tied to them."},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":131,"years":{"first":2004,"last":2026},"societies":["AACR","ASCO","ASTRO","ESMO","IASLC","ISPOR Europe"],"shown":3,"withheld":128,"rows":[{"title":"Abstract 6820: Age-related clonal hematopoiesis drives immune remodeling that promotes lung cancer and alters neoadjuvant chemo-immunotherapy outcomes","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-6820","source_url":"https://doi.org/10.1158/1538-7445.am2026-6820","status":"verified"},{"title":"Cross-stage validation of a multimodal machine learning model to predict pathological complete response to neoadjuvant chemotherapy or chemoimmunotherapy in resectable stage III non–small cell lung cancer.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.8022","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.8022","status":"verified"},{"title":"Impact of neoadjuvant durvalumab (D) on tumor microenvironment (TME) features and their association with event-free survival (EFS) in patients with resectable NSCLC (R-NSCLC) from the phase 3 AEGEAN trial.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.8015","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.8015","status":"verified"}],"source":"congress"},"publications":{"total":3,"shown":3,"withheld":0,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Peripheral memory B cell population maintenance and long-term survival after perioperative chemoimmunotherapy in NSCLC (NADIM trial).","year":2025,"journal":"Oncoimmunology","types":["Clinical Trial, Phase II","Journal Article","Multicenter Study"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40468805/","status":"verified"},{"title":"Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy.","year":2022,"journal":"Journal for immunotherapy of cancer","types":["Clinical Trial","Journal Article","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/36171009/","status":"verified"},{"title":"Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial.","year":2021,"journal":"Clinical and translational medicine","types":["Journal Article","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/34323406/","status":"verified"}],"source":"publications"},"recognition":{"roles":{"total":1,"shown":1,"rows":[{"value":"Secretary, Grupo Español de Cáncer de Pulmón (GECP)","source_url":"https://www.audible.com.au/podcast/LungPod-GECP-Especial-ADCS/episodes/B0DQYB74FX","status":"provisional","collected_at":"2026-11-09"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Profesor/a Asociado/a, Medicina Clínica (Universidad Miguel Hernández, per UMH research portal; university not named on the page text)","source_url":"https://research.umh.es/vivo/display/per_153379","status":"provisional","collected_at":"2026-11-09"}]},"media":{"total":2,"shown":2,"rows":[{"value":"LungPod (GECP) Episode 4, interview with Dr. Bartomeu Massuti (podcast, 30 Apr 2025)","source_url":"https://www.audible.com.au/podcast/LungPod-GECP-Especial-ADCS/episodes/B0DQYB74FX","status":"verified","collected_at":"2026-11-09"},{"value":"Interview in Alicante Plaza, \"Massutí, oncólogo: España está entre los primeros países en investigación de cáncer de pulmón\" (published 23/11/2023)","source_url":"https://alicanteplaza.es/alicanteplaza/massutioncologoespaaestaentrelosprimerospaiseseninvestigaciondecancerdepulmon","status":"verified","collected_at":"2026-11-09"}]}},"similar":[{"name":"Marc Ladanyi","slug":"marc-ladanyi","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Anatomic Pathology","url":"https://www.findmykol.com/kol/marc-ladanyi","json_url":"https://www.findmykol.com/kol/marc-ladanyi/profile.json"},{"name":"Ignacio Wistuba","slug":"ignacio-wistuba","institution":"Moffitt Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/ignacio-wistuba","json_url":"https://www.findmykol.com/kol/ignacio-wistuba/profile.json"},{"name":"Pasi Janne","slug":"pasi-janne","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/pasi-janne","json_url":"https://www.findmykol.com/kol/pasi-janne/profile.json"},{"name":"John Minna","slug":"john-minna","institution":"University of Texas Southwestern Medical Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/john-minna","json_url":"https://www.findmykol.com/kol/john-minna/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"congress":128}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-09"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-09"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-09"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-09"}},"methodology_url":"https://www.findmykol.com/about#methodology"}